General Archive

  • ER 1926 - 2022
    News releases

    Her Majesty Queen Elizabeth II

    We at LifeArc are deeply saddened by the passing of Her Majesty Queen Elizabeth II.

    Read more

  • Eczema dermatitis on hands and feet.
    News releases

    LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million

    First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its science

    Read more

  • Melanie Lee, CEO, on a pink chair in a pink room
    Articles

    Seven questions about LifeArc’s 2030 ambitions

    Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.

    Read more

  • Escherichia Coli (E. Coli.) cells or bacteria under microscope
    News releases

    LifeArc helps create new MRC spin-out company

    The new company aims to re-programme microbes to enable new materials to be produced – such as drugs and biodegradable…

    Read more

  • Woman and child waling into the entrance of the Great Ormond Street Hospital
    News releases

    Driving translational research into childhood rare diseases

    Four grants awarded to projects that aim to translate research discoveries into benefits for children affected by rare diseases

    Read more

  • Progress of building work at the gene therapy innovation hub
    Articles

    Advancing novel gene therapies into the clinic

    Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.

    Read more

  • Kovilen-Sawmynaden-2017
    Articles

    Study reveals potential new way to treat colorectal cancer

    Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.

    Read more

  • Mehak Mumtaz
    Articles

    Startup wins first Advise & Connect Innovation Award

    iLOF is a startup that has a novel technology with the potential to transform personalised medicine.

    Read more

  • " "
    Articles

    Milner Therapeutics Institute and LifeArc extend strategic partnership

    Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics

    Read more

  • David Setters, who is living with MND
    News releases

    New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease

    Collaboration will work together to find solutions to MND within years, not decades

    Read more

  • Older patient with carer
    News releases

    New £30 million translational partnership will accelerate development of new treatments for people with dementia

    Funding will accelerate development of new diagnostic tests, treatments, and devices for people with dementia.

    Read more

  • Scientist in the antibody humanisation lab at LifeArc
    News releases

    Promising new asthma medicine ready to enter early clinical trials

    LifeArc scientists instrumental to the development of the world’s first anti-IL17BR antibody, now being trialled as a treatment for severe…

    Read more